Effect of additional administration of tacrolimus in patients with rheumatoid arthritis treated with biologics.

Fukushima journal of medical science

Volumn 57, Issue 2, 2011, Pages 54-59

  Miyata, Masayuki ^a   Asano, Tomoyuki ^b   Satoh, Shuzo ^b  

^a Fukushima Red Cross Hospital   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; C REACTIVE PROTEIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; TACROLIMUS;

AGED; ARTICLE; BLOOD; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MALE; MIDDLE AGED; RHEUMATOID ARTHRITIS;

AGED; ARTHRITIS, RHEUMATOID; BIOLOGICAL AGENTS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; MIDDLE AGED; TACROLIMUS;

EID: 84862252993     PISSN: None     EISSN: 21854610     Source Type: Journal    
DOI: 10.5387/fms.57.54     Document Type: Article

References (0)